To assess the assumptions underlying our IV estimator we selected a stratified random sample of patients with CKD from our study population based on (1) observed ACEI/ARB use after index stroke, (2) local area ACEI/ARB area treatment rates (ATRs) after stroke (high or low ACEI/ARB areas using patients from the highest and lowest quintiles, respectively), and (3) geographic region, using the four U.S. Census Geographical Regions: Northeast (NE), Midwest (MW), South (ST), and West (WT; US Census Bureau, 2014). To evaluate assumptions underlying the IV estimator, we grouped patients based on local area ACEI/ARB use rates and tested the mean differences in each abstracted measure between groups.
accuracy. To verify that data were abstracted accurately and uniformly across all members of the abstraction team, results from all three IQC rounds were aggregated by conceptual domains and agreement was calculated. We calculated a kappa statistic for each categorical variable and each associated domain; for continuous variables (e.g., lab values) we calculated intra-class correlations (ICC) -then also summarized them into domain scores.
Analyses
Because of the voluntary nature of the response from the facilities, we analyzed the characteristics of patients for whom we received charts versus those for whom we did not by linking patient-level beneficiary and Medicare A and B claims from the index stroke stay to our requested and received medical charts. We also linked data from the CMS POS file to obtain geographic information and additional characteristics of the hospital facilities to allow for comparison of responding versus non-responding facilities.
Results
A total of 1,439 complete chart sets were requested and 956 were received for an overall response rate of 66.4%; of these, 840 were abstracted. Of the chart sets received, 17 of them were not abstracted due to missing information such as initial intake/history, medication administration list, or discharge instructions; and 84 were not abstracted because they came from a stratum for which the necessary number of charts had been received and abstracted (i.e., we obtained more charts than we needed for some of the strata). For five cases, a transfer occurred, and the other chart was not received, rendering the case unusable for abstraction. Figure S1 documents the medical chart sample requested, received, and abstracted. Nonresponse analysis revealed that very few differences between patients whose charts were received versus not received (Table S1 ). Examination of claims-based measures at the patientlevel indicated that patients for whom we received charts were more likely white (83.2% versus 77.4%, p=.005), less likely to be dually enrolled in Medicare and Medicaid (33.6% versus 38.5%, p <0.05), were less likely to have required an acute care transfer for the stroke hospitalization (0.9% versus 4.4%; p < 0.0001), and had shorter average acute care lengths of stay (LOS) (5.67 days versus 6.37 days; p < 0.001). Other demographics, as well as characteristics of the index stroke, prior comorbid conditions, and the complications of index stay were all comparable.
Examination of the hospital facility-level nonresponse (Table S2 ) revealed that we were more likely to receive charts from facilities in the West region of the U.S. (26.7% versus 20.5%; p < 0.01). We were also less likely to receive charts from larger facilities (300+ beds) (45.1% versus 60.4%; p < 0.001). For internal quality control (IQC), we calculated a kappa statistic for each item and then summarized the kappa statistics for each conceptual area; for continuous variables (e.g., lab values) we calculated intra-class correlations (ICC) and summarized them for each conceptual area. Figure A2 illustrates the summary scores for each conceptual area, along with the error bars for the standard deviation. Since the kappa statistic corrects for agreement by chance, values 0.41-0.60 are often considered "moderate" agreement, 0.61 -0.80 is "substantial agreement", and scores higher than this are considered "very high" or near perfect agreement. 11, 12 ICC are interpreted similarly. All conceptual areas had moderate or better agreement between raters, with four conceptual areas having very high agreement (administrative variables, vitals during stay, lab test values during stay and administration of medications). We originally asked abstractors to find and document use in the charts of standardized stroke severity scores that have been used in previous prospective clinical studies, such as the Modified Rankin Score or Barthel Index. Unfortunately, pilot testing revealed that these standardized scores were almost universally unreported. Therefore, instead, we identified the key concepts from these stroke assessment instruments, and directly measured each of the clinical domains with our abstraction tool to address items such as activities of daily living (ADLs) and functional deficits.
Limitations
Study abstractors found little consistent information in the charts with respect to measures of stroke severity. We originally asked abstractors to find and document use in the charts of standardized stroke severity scores that have been used in previous prospective clinical studies, such as the Modified Rankin Score or Barthel Index. Unfortunately, pilot testing revealed that these standardized scores were almost universally unreported. We attempted to isolate the conditions that underlie these measures in the charts. However, uncertainty remains as to whether individual conditions not reported in a chart did not actually exist for a patient or were simply not specifically recorded in the charts at individual institutions. For example, we feel confident that patients who were reported in the charts to have "problems with self-feeding" had this problem. We cannot be certain, though, because of reporting differences across institutions, whether patients who were not reported to have "problems with self-feeding" did not have these problems. As a result, our results are conditional on the assumption that chart reporting differences across institutions are not correlated with ACE/ARB treatment choices or local area ACE/ARB prescribing rates.
Future Research
Abstractors reported substantial variation in the quality and extent of information available in the charts across institutions. Future research requiring data abstracted from patient charts across institutions perhaps should also include measures of chart "completeness" to help ensure that conditions observed for a patient are recorded. 
Data S3. Instrument Strategy Background.
"Instruments" in instrumental variable estimation are measured factors having a strong relationship with treatment choice and are assumed to have no direct relationship to study outcomes or other unmeasured factors related to study outcomes. With these characteristics, instruments provide a natural experiment of treatment choice across patients. 30 Measures of local area practice styles have been shown to be a practical and rich source for instrument development. [31] [32] [33] The approach used here to measure local area practice styles has explained larger portions of treatment variation than other approaches and effectively balanced measured confounding variables. 34 We produced ZIP code-specific practice style measures reflecting the ACEI/ARB treatment choices for Medicare stroke patients living within a driving distance of each patient's ZIP code. Driving times were expanded around each ZIP code adding patients from additional ZIP codes until a defined threshold number of patients were found. For the patients around each ZIP code, an area treatment ratio (ATR) was estimated as the ratio of the number of these patients that used ACEI/ARBs after stroke over the sum of the predicted probabilities of these same patients receiving ACEI/ARBs after stroke. Predicted treatment probabilities were estimated for each patient based on a logistic model of treatment choice over all the stroke patients in our study using baseline covariates in Supplement A as dependent variables. A ZIP code with an ATR greater than 1 suggests greater provider preference in the local area for prescribing an ACEI/ARB after stroke than the average ZIP code area, and an ATR less than 1 suggests lower preference than average.
Data S4.

2-Stage Least Squares (2SLS) Instrumental Variable Estimator Background
2SLS estimation involved estimation of first-stage treatment choice equation of the form:
(1) A i = β 0 + β 1 •X i + β 2 •R i , where Ai equals 1 if patient "i" used an ACEI/ARB in the 30 days after index stroke discharge, 0 otherwise; Xi is vector containing all measured covariates; and Ri represents a set of variables describing the ACEI/ARB area treatment ratio (ATR) in ZIP code of the residence of patient "i".
As robustness checks we used several approaches to specify Ri. We used standard F-test to assess the statistical significance of variables used to specify the instruments in equation (1). 35 The second stage outcome models were specified as follows:
Yi equals 1 of the outcome occurs for patient "i", 0 otherwise; and Xi is defined as above. ́ equals the predicted probability that patient "i" received an ACEI/ARB from equation (1) . The parameter α 1 equals the absolute effect of ACEI/ARB use on the probability of outcome Yi occurring, and is an estimate of the local average treatment effect (LATE) of ACEI/ARB use for those patients whose choice of ACEI/ARB was sensitive to local area practice styles. [36] [37] [38] [39] We estimated α 1 for the full sample and on the subsets based on CKD status. As each dependent variable in this study is a binary variable, these linear specifications yield direct estimates of absolute LATEs. 40 Because of our large sample size, our parameter estimates will be distributed normally via the central limit theorem regardless of the distribution of the underlying error term. [41] [42] [43] Each 2SLS model was estimated with robust standard error methods using STATA software. We tested for differences in ACEI/ARB LATE estimates between the CKD and non-CKD patients 44 and used bootstrapping to contrast the empirical distributions of treatment effects between CKD and non-CKD patients. 45 Over-identification tests were performed to assess whether our assumed exclusion of the instruments (Ri) from equation (2) 
